JP5703528B2 - 患者の体内に存在する物質の質量又は濃度を表す値を評価するための方法及び装置 - Google Patents

患者の体内に存在する物質の質量又は濃度を表す値を評価するための方法及び装置 Download PDF

Info

Publication number
JP5703528B2
JP5703528B2 JP2012528262A JP2012528262A JP5703528B2 JP 5703528 B2 JP5703528 B2 JP 5703528B2 JP 2012528262 A JP2012528262 A JP 2012528262A JP 2012528262 A JP2012528262 A JP 2012528262A JP 5703528 B2 JP5703528 B2 JP 5703528B2
Authority
JP
Japan
Prior art keywords
patient
mass
concentration
value
distribution space
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2012528262A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013503727A (ja
Inventor
ポール チャムニー，
ポール チャムニー，
ウルリッチ モイスル，
ウルリッチ モイスル，
ピーター ウェイベル，
ピーター ウェイベル，
ネスター ヴェラスコ，
ネスター ヴェラスコ，
ヴォルカー ニーア，
ヴォルカー ニーア，
セバスチャン ウィースコッテン，
セバスチャン ウィースコッテン，
Original Assignee
フレゼニウス メディカル ケア ドイッチェランド ゲゼルシャフト ミット ベシュレンクテル ハフツング
フレゼニウス メディカル ケア ドイッチェランド ゲゼルシャフト ミット ベシュレンクテル ハフツング
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by フレゼニウス メディカル ケア ドイッチェランド ゲゼルシャフト ミット ベシュレンクテル ハフツング, フレゼニウス メディカル ケア ドイッチェランド ゲゼルシャフト ミット ベシュレンクテル ハフツング filed Critical フレゼニウス メディカル ケア ドイッチェランド ゲゼルシャフト ミット ベシュレンクテル ハフツング
Publication of JP2013503727A publication Critical patent/JP2013503727A/ja
Application granted granted Critical
Publication of JP5703528B2 publication Critical patent/JP5703528B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14542—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring blood gases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
    • A61B5/4839—Diagnosis combined with treatment in closed-loop systems or methods combined with drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7235—Details of waveform analysis
    • A61B5/7264—Classification of physiological signals or data, e.g. using neural networks, statistical classifiers, expert systems or fuzzy systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters
    • A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters electrical or electronic
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
    • G16H10/65—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records stored on portable record carriers, e.g. on smartcards, RFID tags or CD
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
    • A61B5/053—Measuring electrical impedance or conductance of a portion of the body
    • A61B5/0537—Measuring body composition by impedance, e.g. tissue hydration or fat content

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medical Informatics (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Artificial Intelligence (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Fuzzy Systems (AREA)
  • Physiology (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Mathematical Physics (AREA)
  • Evolutionary Computation (AREA)
  • Psychiatry (AREA)
  • Signal Processing (AREA)
  • Data Mining & Analysis (AREA)
JP2012528262A 2009-09-09 2010-09-07 患者の体内に存在する物質の質量又は濃度を表す値を評価するための方法及び装置 Expired - Fee Related JP5703528B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09011550A EP2295097A1 (en) 2009-09-09 2009-09-09 Method and apparatus for evaluating values representing a mass or a concentration of a substance present within the body of a patient
EP09011550.2 2009-09-09
PCT/EP2010/005480 WO2011029569A1 (en) 2009-09-09 2010-09-07 Method and apparatus for evaluating values representing a mass or a concentration of a substance present within the body of a patient

Publications (2)

Publication Number Publication Date
JP2013503727A JP2013503727A (ja) 2013-02-04
JP5703528B2 true JP5703528B2 (ja) 2015-04-22

Family

ID=41319576

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012528262A Expired - Fee Related JP5703528B2 (ja) 2009-09-09 2010-09-07 患者の体内に存在する物質の質量又は濃度を表す値を評価するための方法及び装置

Country Status (10)

Country Link
US (2) US9301716B2 (enExample)
EP (2) EP2295097A1 (enExample)
JP (1) JP5703528B2 (enExample)
KR (1) KR101861197B1 (enExample)
CN (1) CN102481102B (enExample)
AU (1) AU2010294525B2 (enExample)
BR (1) BR112012005158B8 (enExample)
CA (1) CA2773495C (enExample)
IN (1) IN2012DN02058A (enExample)
WO (1) WO2011029569A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9750862B2 (en) 2011-04-29 2017-09-05 Medtronic, Inc. Adaptive system for blood fluid removal
US9757591B2 (en) * 2013-02-11 2017-09-12 Bayer Healthcare Llc Methods and systems for monitoring an automated infusion system
US20150100009A1 (en) * 2013-10-09 2015-04-09 Medtronic, Inc. Surgical and Post Surgical Fluid Management
AU2015264323B2 (en) * 2014-05-20 2018-10-04 Fresenius Medical Care Holdings, Inc. Absolute blood volume measurement using ultrafiltration pulsing
EP3606440B1 (en) * 2017-04-04 2024-08-07 Cella Medical, Inc. Method and device for determining the hydration, fitness and nutrition status of a human body
CA3156801A1 (en) 2019-10-04 2021-04-08 Fresenius Medical Care Holdings, Inc. Techniques for determining patient blood characteristics during a dialysis process

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4895163A (en) 1988-05-24 1990-01-23 Bio Analogics, Inc. System for body impedance data acquisition
US5280429A (en) 1991-04-30 1994-01-18 Xitron Technologies Method and apparatus for displaying multi-frequency bio-impedance
JPH06218046A (ja) 1993-01-25 1994-08-09 Sanyo Electric Works Ltd 血液浄化装置
JPH1014899A (ja) * 1996-07-05 1998-01-20 Sekisui Chem Co Ltd 身体組成推計装置及び身体組成推計方法
US6010454A (en) * 1997-05-29 2000-01-04 Aquintel, Inc. Fluid and electrolyte balance monitoring system for surgical and critically ill patients
JP2002053209A (ja) * 2000-08-08 2002-02-19 Kentop:Kk 配置販売業における在庫管理装置および在庫管理方法
EP1205144B1 (en) * 2000-11-06 2002-10-02 Fresenius Medical Care Deutschland GmbH A method and a device for determining the dry weight of a patient with kidney failure
WO2002053209A1 (fr) * 2000-12-27 2002-07-11 Philips Japan, Ltd. Systeme de controle de l'information d'un dispositif de traitement sanguin et de l'information biologique, dispositif de controle de l'information d'un dispositif de traitement sanguin et de l'information biologique, et procede de commande correspondant
US7657292B2 (en) 2001-03-16 2010-02-02 Nellcor Puritan Bennett Llc Method for evaluating extracellular water concentration in tissue
US8135448B2 (en) * 2001-03-16 2012-03-13 Nellcor Puritan Bennett Llc Systems and methods to assess one or more body fluid metrics
US20040242977A1 (en) * 2003-06-02 2004-12-02 Dosmann Andrew J. Non-invasive methods of detecting analyte concentrations using hyperosmotic fluids
CN1960672B (zh) 2004-06-29 2010-05-12 弗雷森纽斯医疗护理德国有限责任公司 确定病人水合和/或营养状况的方法和装置
US7938817B2 (en) * 2004-09-09 2011-05-10 Plc Medical Systems, Inc. Patient hydration system and method
US8956291B2 (en) * 2005-02-22 2015-02-17 Admetsys Corporation Balanced physiological monitoring and treatment system
US8447376B2 (en) * 2006-10-04 2013-05-21 Dexcom, Inc. Analyte sensor
JP5529009B2 (ja) * 2007-05-14 2014-06-25 インぺディメッド リミテッド インジケータを用いるインピーダンス分析方法と分析装置
WO2009115944A1 (en) * 2008-03-17 2009-09-24 Philips Intellectual Property & Standards Gmbh Method and system for automatically controlling a physiological variable of a patient in a closed loop
US9370324B2 (en) * 2008-11-05 2016-06-21 Fresenius Medical Care Holdings, Inc. Hemodialysis patient data acquisition, management and analysis system

Also Published As

Publication number Publication date
IN2012DN02058A (enExample) 2015-08-21
KR20120062741A (ko) 2012-06-14
US10551370B2 (en) 2020-02-04
EP2475409B1 (en) 2020-10-28
CA2773495A1 (en) 2011-03-17
US20160169861A1 (en) 2016-06-16
US20130018245A1 (en) 2013-01-17
CN102481102A (zh) 2012-05-30
EP2295097A1 (en) 2011-03-16
AU2010294525B2 (en) 2015-09-17
WO2011029569A8 (en) 2011-06-30
WO2011029569A1 (en) 2011-03-17
EP2475409A1 (en) 2012-07-18
JP2013503727A (ja) 2013-02-04
US9301716B2 (en) 2016-04-05
AU2010294525A1 (en) 2012-04-05
CA2773495C (en) 2023-10-24
BR112012005158A2 (pt) 2016-05-03
KR101861197B1 (ko) 2018-05-25
CN102481102B (zh) 2015-11-25
BR112012005158B8 (pt) 2021-06-22
BR112012005158B1 (pt) 2020-12-29

Similar Documents

Publication Publication Date Title
JP6184870B2 (ja) 相対血液体積を表す値を計算または近似するための方法およびデバイス
JP6223821B2 (ja) 赤血球生成刺激剤（ｅｓａ）の効果を予測し投与量を決定するための方法及び装置
US10551370B2 (en) Method and apparatus for evaluating values representing a mass or a concentration of a substance present within the body of a patient
JP6208193B2 (ja) ろ過率の制御方法を行うコントローラ、装置及びデバイス
JP5716259B2 (ja) 患者の体液状態及び／又は体液除去に対する感度を評価する方法、コントローラ、及び装置
WO2015056259A1 (en) System and method for improved artificial pancreas management
HK1170968A (en) Method and apparatus for evaluating values representing a mass or a concentration of a substance present within the body of a patient
HK1170968B (en) Method and apparatus for evaluating values representing a mass or a concentration of a substance present within the body of a patient

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20130904

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20140514

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140520

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20140820

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20140827

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140922

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20150127

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20150206

R150 Certificate of patent or registration of utility model

Ref document number: 5703528

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees